Related Experiment Video

Updated: Jun 19, 2026

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy
10:02

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy

Published on: November 3, 2016

Long-term management of children with neuromuscular disorders

Eugen-Matthias Strehle1

  • 1Department of Pediatrics, North Tyneside General Hospital, Rake Lane, North Shields, United Kingdom. strehle@doctors.org.uk

Jornal De Pediatria
|October 16, 2009
PubMed

Insights

This review offers practical guidance for managing rare inherited neuromuscular diseases in children, focusing on Duchenne muscular dystrophy and other genetic myopathies. Regular monitoring and a structured approach are key to improving patient outcomes and quality of life.

Area of Science:

  • Pediatric Neurology
  • Clinical Genetics
  • Neuromuscular Disorders

Background:

  • Duchenne muscular dystrophy is the most common genetic myopathy.
  • Many inherited neuromuscular diseases are individually rare with limited clinical information.
  • This review draws on pediatric muscle clinic experience.

Purpose of the Study:

  • To provide practical guidance and treatment plans for frequently encountered problems in pediatric neuromuscular disorders.
  • To address the management of rare inherited myopathies and neuropathies.
  • To improve clinical information availability for rare diseases.

Main Methods:

  • A MEDLINE search was conducted for recent articles on managing childhood inherited myopathies and neuropathies.
  • Descriptive statistics were used to evaluate a patient cohort of 200 children.
  • Clinical experience from a pediatric muscle clinic informed the review.

Main Results:

  • Duchenne muscular dystrophy comprised nearly half of diagnoses.
  • Spinal muscular atrophy (12%), Becker muscular dystrophy (7%), and myotonic dystrophy (7%) were also significant.
  • A notable 9% of patients had an undiagnosed myopathy.

Conclusions:

  • Regular early review by health professionals is crucial for increasing life expectancy and quality of life in children with chronic neuromuscular disorders.
  • A structured approach to monitoring all affected organ systems is recommended for physicians.
  • Early and consistent management can significantly impact long-term patient outcomes.
Abstract

More Related Videos

Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy07:20

Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy

Published on: August 9, 2024

Related Concept Videos

Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...